DNB Asset Management AS Has $30.11 Million Stock Position in CME Group Inc. $CME

DNB Asset Management AS increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 45.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 110,256 shares of the financial services provider’s stock after buying an additional 34,298 shares during the period. DNB Asset Management AS’s holdings in CME Group were worth $30,109,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after buying an additional 588,509 shares in the last quarter. Ameriprise Financial Inc. lifted its position in CME Group by 2.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after buying an additional 130,848 shares in the last quarter. Sanders Capital LLC acquired a new position in CME Group during the 3rd quarter worth about $1,006,932,000. Franklin Resources Inc. lifted its position in CME Group by 0.6% during the 3rd quarter. Franklin Resources Inc. now owns 3,381,133 shares of the financial services provider’s stock worth $913,548,000 after buying an additional 20,213 shares in the last quarter. Finally, Invesco Ltd. lifted its position in CME Group by 23.0% during the 3rd quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock worth $764,725,000 after buying an additional 528,358 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $298.86 on Friday. The company has a market capitalization of $108.29 billion, a price-to-earnings ratio of 25.50, a P/E/G ratio of 3.61 and a beta of 0.23. The firm’s 50 day simple moving average is $298.07 and its 200 day simple moving average is $288.06. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $257.17 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the company posted $2.80 EPS. CME Group’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 12.26 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is 44.37%.

Analyst Upgrades and Downgrades

CME has been the topic of several research reports. Morgan Stanley reduced their price target on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. JPMorgan Chase & Co. upped their target price on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. The Goldman Sachs Group cut their target price on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Erste Group Bank upgraded shares of CME Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, March 5th. Finally, Rothschild & Co Redburn cut their target price on shares of CME Group from $340.00 to $316.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of “Moderate Buy” and an average price target of $305.29.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. The new contract would be CME’s first-ever market-cap weighted futures product and expands its regulated crypto offerings, which investors may view as a growth driver. Article: CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Reports that Interactive Brokers is integrating CME event contracts into a unified prediction-markets platform highlight CME’s growing relevance in new trading products and could support longer-term volume opportunities. Article: Interactive Brokers Debuts All-in-One Prediction Market Portal
• Positive Sentiment: Coverage of CME’s annual meeting preliminary results was routine governance news, but it showed no apparent disruption to the company’s leadership or shareholder base. Article: CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Multiple reports said CME and Intercontinental Exchange are lobbying U.S. regulators to increase scrutiny of Hyperliquid, arguing that the unregulated platform could affect price discovery in oil and crypto markets. This is more about competitive/regulatory positioning than a direct business event for CME, but it may be seen as CME defending the regulated futures ecosystem. Article: CME, ICE Push US to Curb Crypto’s Offshore Oil Trading Upstart
• Neutral Sentiment: Broader market commentary referenced CME’s FedWatch tool showing higher odds of a Fed hike later in 2026, but this is an indirect macro signal rather than company-specific news. Article: The Bond Market Just Fired A Warning Shot At The AI Rally — Fed Hike Ahead

Insiders Place Their Bets

In other CME Group news, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares in the company, valued at $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 7,791 shares of company stock worth $2,489,421. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.